Cite

HARVARD Citation

    Manic, G. et al. (2018). CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells. Gut. 67 (5), pp. 903-917. [Online]. 
  
Back to record